Hospital Medicine

  • Hampton hump in acute pulmonary embolism
    Sovik De Sirkar, MD, Joshua Newman, MD, Sorcha Allen, MB, BCh, BAO, Ahmed Elkaryoni, MD, Alexandru Marginean, MD and Amir Darki, MD, MSc
    Cleveland Clinic Journal of Medicine May 2022, 89 (5) 236-238; DOI: https://doi.org/10.3949/ccjm.89a.21058

    A 50-year-old patient presented with worsening dyspnea and cough with bilateral swelling of the lower extremities, with left-side swelling greater than right-side swelling.

  • Treating anemia: It’s not just the EPO
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine April 2022, 89 (4) 174-175; DOI: https://doi.org/10.3949/ccjm.89b.04022

    Long-term effects of treatment with the new oral inhibitors of prolyl hydroxylase will need to be carefully monitored, as prolyl hydroxylase is a key structural component of diverse proteins.

  • The devil is in the details: Approach to refractory hypokalemia
    Carmen Elena Cervantes, MD, Karthik Meiyappan Udayappan, MD and Duvuru Geetha, MBBS, MD
    Cleveland Clinic Journal of Medicine April 2022, 89 (4) 182-188; DOI: https://doi.org/10.3949/ccjm.89a.21013

    The authors illustrate a stepwise approach to the evaluation of acid-base disturbances.

  • Glycemic targets in the ICU: A look back, and ahead
    Keren Zhou, MD
    Cleveland Clinic Journal of Medicine April 2022, 89 (4) 189-190; DOI: https://doi.org/10.3949/ccjm.89a.21127

    Much work is still needed to understand the nuances of glycemic targets in critically ill patients, and to learn how to take advantage of evolving technology to improve glycemic control.

  • Glycemic control in the critically ill: Less is more
    Ghaith Alhatemi, MD, Haider Aldiwani, MD, Rafal Alhatemi, MD, Marwah Hussein, MD, Suzan Mahdai, MD and Berhane Seyoum, MD
    Cleveland Clinic Journal of Medicine April 2022, 89 (4) 191-199; DOI: https://doi.org/10.3949/ccjm.89a.20171

    The authors discuss findings from key trials, metrics of glycemic control, and recommendations of professional societies for target blood glucose ranges in critically ill patients.

  • Anemia of chronic kidney disease: Will new agents deliver on their promise?
    Anemia of chronic kidney disease: Will new agents deliver on their promise?
    Tarek Souaid, MD, Jonathan Taliercio, DO, James F. Simon, MD, MBA, Ali Mehdi, MD, MEd and Georges N. Nakhoul, MD, MEd
    Cleveland Clinic Journal of Medicine April 2022, 89 (4) 212-222; DOI: https://doi.org/10.3949/ccjm.89a.21100

    A review of the pathophysiology of anemia of chronic kidney disease, major clinical trials, and novel therapies.

  • Does my hospitalized patient need an NPO-after-midnight order preoperatively?
    Cleveland Clinic Journal of Medicine April 2022, 89 (4) 223;

    The following article in the February 2022 issue contained an error: Chapman T, Sinz E, McGillen B. Does my hospitalized patient need an NPO-after-midnight order preoperatively? Cleve Clin J Med 2022; 89(2):69–70. doi:10.3949/ccjm.89a.21061

  • Does my hospitalized patient need an NPO-after-midnight order preoperatively?
    Tyler Chapman, DO, Elizabeth Sinz, MD, MEd and Brian McGillen, MD, FACP, SFHM
    Cleveland Clinic Journal of Medicine February 2022, 89 (2) 69-70; DOI: https://doi.org/10.3949/ccjm.89a.21061

    Delays and postponements of surgical procedures are common, and NPO-after-midnight orders in these situations can result in prolonged periods without oral intake.

  • Recurrent anemia in a patient with chronic lymphocytic leukemia
    Sassine Ghanem, MD and Jason Gonsky, MD, PhD
    Cleveland Clinic Journal of Medicine February 2022, 89 (2) 91-98; DOI: https://doi.org/10.3949/ccjm.89a.21025

    New episodes of anemia do not automatically imply disease progression, and each should be evaluated completely.

  • Sometimes the look is worth the walk
    Brian F. Mandell, MD
    Cleveland Clinic Journal of Medicine January 2022, 89 (1) 4-5; DOI: https://doi.org/10.3949/ccjm.89b.01022

    We do not routinely look at blood smears today. The need for expediency and efficiency limit the time spent on activities with a low yield for influencing care. And yet, for some conditions in some patients, going back to the basics can be clinically rewarding, and even memorable.

Pages